AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 11th, 2025 • Rafael Holdings, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 11th, 2025 Company Industry JurisdictionTHIS AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of January 30, 2025, by and between Cyclo Therapeutics Inc., a Nevada corporation with its principal place of business at 6714 NW 16th Street, Suite B, Gainesville, FL 32653 (the “Company”) and N. Scott Fine (the “Executive”) (collectively, the “Parties”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 11th, 2025 • Rafael Holdings, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 11th, 2025 Company Industry JurisdictionTHIS AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of January 30, 2025, by and between Cyclo Therapeutics Inc., a Nevada corporation with its principal place of business at 6714 NW 16th Street, Suite B, Gainesville, FL 32653 (the “Company”) and Joshua Fine (the “Executive”) (collectively, the “Parties”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 11th, 2025 • Rafael Holdings, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 11th, 2025 Company Industry JurisdictionTHIS AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of January 30, 2025, by and between Cyclo Therapeutics Inc., a Nevada corporation with its principal place of business at 6714 NW 16th Street, Suite B, Gainesville, FL 32653 (the “Company”) and Michael Lisjak (the “Executive”) (collectively, the “Parties”).